Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An Engineered IgG-VHH Bispecific Antibody against SARS-CoV-2 and Its Variants.
Chi H, Wang L, Liu C, Cheng X, Zheng H, Lv L, Tan Y, Zhang N, Zhao S, Wu M, Luo D, Qiu H, Feng R, Fu W, Zhang J, Xiong X, Zhang Y, Zu S, Chen Q, Ye Q, Yan X, Hu Y, Zhang Z, Yan R, Yin J, Lei P, Wang W, Lang G, Shao J, Deng Y, Wang X, Qin C. Chi H, et al. Among authors: luo d. Small Methods. 2022 Dec;6(12):e2200932. doi: 10.1002/smtd.202200932. Epub 2022 Oct 27. Small Methods. 2022. PMID: 36300882 Free PMC article.
Transient acquisition of cross-species infectivity during the evolution of SARS-CoV-2.
Chen Q, Huang XY, Sun MX, Li RT, Gu H, Tian Y, Zhang RR, Luo D, Zhou C, Zhang Y, Cao T, Zhang NN, Deng YQ, Li XF, Qin CF. Chen Q, et al. Among authors: luo d. Natl Sci Rev. 2021 Sep 4;8(11):nwab167. doi: 10.1093/nsr/nwab167. eCollection 2021 Nov. Natl Sci Rev. 2021. PMID: 34873448 Free PMC article. No abstract available.
Rational development of a combined mRNA vaccine against COVID-19 and influenza.
Ye Q, Wu M, Zhou C, Lu X, Huang B, Zhang N, Zhao H, Chi H, Zhang X, Ling D, Zhang RR, Li Z, Luo D, Huang YJ, Qiu HY, Song H, Tan W, Xu K, Ying B, Qin CF. Ye Q, et al. Among authors: luo d. NPJ Vaccines. 2022 Jul 26;7(1):84. doi: 10.1038/s41541-022-00478-w. NPJ Vaccines. 2022. PMID: 35882870 Free PMC article.
Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants.
Wang R, Huang X, Cao T, Sun C, Luo D, Qiu H, Wu M, Huang X, Yu C, Li J, Kong D, Ma J, Zhang X, Hu P, Zhang Y, Luo C, Zhao H, Li Y, Deng Y, Qin C, Xie L. Wang R, et al. Among authors: luo c, luo d. Virology. 2022 Nov;576:61-68. doi: 10.1016/j.virol.2022.09.003. Epub 2022 Sep 20. Virology. 2022. PMID: 36174448 Free PMC article.
5,610 results